^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    MSK-IMPACT Heme

    Company:
    Memorial Sloan-Kettering Cancer Center
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    MSK-IMPACT Heme uses the same technology as MSK-IMPACT. It looks for mutations and other important molecular changes in blood cancers, including leukemia, lymphoma, and multiple myeloma. It looks for mutations in 468 genes that can be present in these blood cancers. The “Heme” part of the name is short for “hematology,” the study of blood.
    Cancer:
    Leukemia, Lymphoma, Multiple Myeloma
    Method:
    Next-Generation Sequencing (NGS)